about
Minocycline: therapeutic potential in psychiatryFuture pharmacological treatments for substance use disordersNatural rewards, neuroplasticity, and non-drug addictionsN-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of actionEpigenetics of nicotine: another nail in the coughingGlutamate transporter 1: target for the treatment of alcohol dependenceDrug withdrawal conceptualized as a stressor.Targeting glutamate uptake to treat alcohol use disordersRole of nucleus accumbens glutamatergic plasticity in drug addictionModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionMetabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant DependencePotential role of N-acetylcysteine in the management of substance use disordersMechanisms of psychostimulant-induced structural plasticityPathways and networks-based analysis of candidate genes associated with nicotine addictionStress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nucleiPharmacotherapies for Overeating and Obesity.Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings.Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.NrCAM-regulating neural systems and addiction-related behaviors.Critical role of peripheral drug actions in experience-dependent changes in nucleus accumbens glutamate release induced by intravenous cocaineGlutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats.Metabolite levels in the brain reward pathway discriminate those who remain abstinent from those who resume hazardous alcohol consumption after treatment for alcohol dependence.Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependenceAmphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings.Effects of chronic administration of drugs of abuse on impulsive choice (delay discounting) in animal models.Negative Affect and Excessive Alcohol Intake Incubate during Protracted Withdrawal from Binge-Drinking in Adolescent, But Not Adult, Mice.Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking.Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in miceEffects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats.Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodelingGlial dysfunction in abstinent methamphetamine abusers.Harnessing neuroplasticity for clinical applications.System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.Change of cystine/glutamate antiporter expression in ethanol-dependent rats.Progesterone Reduces Cocaine Use in Postpartum Women with a Cocaine Use Disorder: A Randomized,Double-Blind StudyThe neurobiology of alcohol consumption and alcoholism: an integrative historyNicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoningDesigning Novel Nanoformulations Targeting Glutamate Transporter Excitatory Amino Acid Transporter 2: Implications in Treating Drug Addiction.
P2860
Q22241418-659639CD-E988-4D77-996B-5D091FFD184BQ22242633-F899CCD2-6B99-43AB-97DE-D77AF4B331C3Q22251254-EBD0F029-222A-4425-8258-78668858C1EFQ24615952-65BEA639-1F10-4F64-8ACC-EA7966FBE570Q24616185-953BCC28-1C71-48BE-BF88-B42AF7DFC37CQ26861666-2ACE72DF-7B9B-49E7-A24A-3AA6513FAAE2Q26997989-EC72C484-3883-4132-AE73-771E03013CF3Q27002488-F9DBEF32-C0D5-4F0F-8CB5-7B8592343016Q27013753-40378EB7-193E-4185-B271-520B77B9C6E4Q27014154-ADEC93F3-D983-4AD4-AB47-F489B93AF5CAQ28084494-4A77F30D-1D5E-4D8E-A520-FAF8ABC77577Q28306130-115A5AC7-C075-4FF2-9064-FAEBAB45BC80Q28389962-CFC7F6DD-667B-446F-8CBC-79E2C591C2C6Q28547199-051F4C78-A11A-4020-A7A9-249D2A4B9211Q28573964-075E3D3A-C64D-4904-8720-BF7AC4AF3612Q30351879-903326EF-1EB1-436E-85D5-32630654AD94Q30367006-5DED4BFC-D881-44AE-A2A0-7D094E41C2E5Q30407769-796B5A91-7BAF-4E34-BC45-D1BAECD5F2A9Q30437184-C883CDFD-164D-4C00-B229-9A8C918F612AQ30525650-D15738F6-D8A4-4D94-9EB1-0BD945232C0BQ30660440-20D62C18-A5E6-49F0-9069-71E1E502C212Q33555649-95BE2C55-2FFD-43BF-A1C9-DA16289403C8Q33739510-658A2E54-3BA9-41E2-A407-A5204AC9030DQ33788180-9A4544B7-653C-4BB9-8E9A-0916DA65DFB2Q33857112-66A345A0-0B50-46CB-BA5B-BD7730CB94E1Q33859178-1560AAF2-E2D7-4887-B7D1-177DD9EC113BQ33869692-D706E06F-4E6E-49E0-8AC2-ADDD7F0A15DBQ33877750-DFCA2F60-A1F0-4025-84EE-509C0907611EQ33944580-A346DEBE-D439-4E9C-8790-9E54B390BD5EQ33959588-AE71FA6A-C91B-4AFB-BD2F-A2212A4CA2DAQ34068926-164D6D71-AFB3-4E07-87E9-AF9AC4B9DC5BQ34166000-46129C48-35FB-4FDC-A4F9-DA01D7BB7DC5Q34171050-D1E2E6C0-698C-4A64-8DF6-5128B4FFEBE5Q34177415-CCF39E79-3268-4243-903E-46CA3EBCC85DQ34184493-7E6A70A9-AE0A-43FB-A028-6E621695E2F7Q34292046-D40BAB1C-E38F-427D-956C-668C0C8AA63DQ34349367-2CCE0E82-FE2B-4D21-99B7-786DC1EE5BA1Q34378869-8DBA4A12-B46D-4ACA-9231-982EC5C629F9Q34439566-7F178195-1125-462E-85B2-905124C2843EQ34504098-F00F83A9-BB1A-493B-987D-42C936E55B37
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Glutamate transmission in addiction.
@ast
Glutamate transmission in addiction.
@en
type
label
Glutamate transmission in addiction.
@ast
Glutamate transmission in addiction.
@en
prefLabel
Glutamate transmission in addiction.
@ast
Glutamate transmission in addiction.
@en
P2093
P2860
P1433
P1476
Glutamate transmission in addiction.
@en
P2093
Haowei Shen
Lori Knackstedt
Peter W Kalivas
Ryan T Lalumiere
P2860
P304
P356
10.1016/J.NEUROPHARM.2008.07.011
P478
56 Suppl 1
P577
2008-07-16T00:00:00Z